XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating activities:    
Net income (loss) $ 3,091 $ (1,919)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 8,714 6,767
Noncash rental revenue including straight-line rents (2,080) (856)
Amortization of terminated swap agreements and related income tax benefit (1,812)  
Stock-based compensation expense 681 505
Amortization of debt issuance costs 492 407
Losses on early extinguishment of debt 464  
Gain on sales of equipment (203)  
Change in fair value of financial instruments   719
Gain on sales of real estate assets   (342)
Changes in assets and liabilities:    
Other assets 3,426 (100)
Accounts payable and accrued liabilities 130 (505)
Deferred revenue (1,276) (1,659)
Other liabilities (349) 685
Net cash provided by operating activities 11,278 3,702
Investing activities:    
Acquisitions of land and buildings (55,784) (60,100)
Additions to real estate assets (28,459) (10,388)
Deposits on building and land acquisitions (3,488)  
Deferred leasing costs and other (845) (883)
Proceeds from sale of equipment, net of expenses 250  
Proceeds from sales of real estate assets, net of expenses   3,141
Net cash used in investing activities (88,326) (68,230)
Financing activities:    
Principal payments on mortgage loans (63,829) (2,540)
Proceeds from delayed draw term loan and construction loan 60,069  
Dividends paid to stockholders (3,259) (4,562)
Payment of debt issuance costs (1,498) (807)
Proceeds from termination of interest rate swap agreements 1,227  
Proceeds from exercise of stock options 144 168
Proceeds from sale of common stock   108,676
Net cash (used in) provided by financing activities (7,146) 100,935
Net (decrease) increase in cash and cash equivalents and restricted cash (84,194) 36,407
Cash and cash equivalents and restricted cash at beginning of period 160,907 30,675
Cash and cash equivalents and restricted cash at end of period $ 76,713 $ 67,082